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Responsible Innovation in GMO Governance: A way out of the 
Stalemate?  
A case study of the assessment of MON810 in Norway  
ABSTRACT 
GMOs have caused controversy since their introduction to the 
European market. By relying on health and environmental 
risks assessment, decision-making in biotechnology excludes 
a diversity of concerns and stakeholders. Despite increasing 
efforts for public and stakeholder engagement the debate is 
highly polarized. Responsible Innovation might provide a 
way out of the stalemate. By conducting a case study of the 
assessment of MON810 in Norway, this paper explores the 
underlying elements of RI in existing frameworks in order to 
investigate how RI can offer an approach to open up new and 
more responsive governance options in regulating GMOs in 
Europe. The analysis has revealed that key to responsiveness 
is the institutionalization and integrations of all RI 
dimensions in the regulatory framework. 
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INTRODUCTION 
Although Genetically Modified Organisms (GMOs) might 
have the potential for feeding the world more sustainably, 
they have raised a polarizing controversy. Despite the 
complex und uncertain nature of the technology's impacts, by 
relying on scientific assessment of health and environmental 
risk, decision-making has narrowed down the debate about 
GMOs to one of “technical questions” (Gaskell et al, 2004). 
Notwithstanding the diversity of socio-economic, cultural and 
ethical concerns, preferences and attitudes, public skepticism 
has been framed as a risk issue and deviating concerns have 
been labeled as irrational fears, resulting from scientific 
ignorance (Torgersen, 2004; Wynne, 2001).Yet, initiatives to 
educate the public did not increase the acceptance and 
shifting the focus on public engagement has shown little 
success.  
The debate about GMOs is stuck in a stalemate. If policy 
initiatives aimed at reforming the regulation keep narrowly 
focusing on a risk-benefit calculus, then it is likely that 
further attempts to achieve social acceptability will not 
contribute to finding a way out (Macnaghten, Carro-Ripalda 
& Burity, 2015). Instead of boiling down the discussion to 
one of risk and safety, different questions should be posed: 
Could GMOs contribute to sustainable development and 
societal utility? Who will benefit, who will loose? Do they 
have the potential to solve the "grand challenges of our 
time" (von Schomberg, 2013)? 
Nevertheless, the question how governance should engage 
with issues which exceed the risk dimension, is a challenging 
one. Despite initiatives aimed to increase public participation, 
current forms of regulatory governance offer little capacity 
for reflection on the purpose of science or innovation or on 
wider ethical and social impacts. Nevertheless, by 
formulating questions about values, benefits and socio-
economic aspects of a technology as well as questions about 
the very purposes of science and innovation (Jasanoff, 2005; 
Owen et al, 2013), the currently widely discussed concept 
Responsible Innovation (RI) might be a way forth. This thesis 
tries to explore the tools RI can provide to open up the 
debate, being guided by the following research question: 
How can the Responsible Innovation framework offer an 
approach to open up new and more responsive governance 
options in regulating Genetically Modified Organisms in 
Europe? 
To answer this question, a case study has been conducted, 
aiming to detect underlying elements of RI in already 
existing frameworks. Integrating tools to assess sustainability, 
societal utility and ethical considerations, the Norwegian 
framework provides a comprehensive ground for analysis. In 
particular, the assessment  of the Bt-maize MON810 is 
examined in order to explore how elements of RI are 
reflected in the Norwegian regulatory framework and what 
RI can add to these elements in order to make the governance 
framework more responsive. Owen et. al.'s (2013) 
anticipation-reflexivity-inclusion-responsiveness framework 
(ARIR-Framework ) will be applied to the Norwegian case, 1
in order to examine if the four significant procedural 
dimensions of RI might reveal possible governance options 
that could be adopted by EU Member States as well.  
Limits can be seen in the narrow range of practical 
experiences with the RI approach. Nevertheless, the aim is 
not to provide a RI tool kit but rather to contribute one input 
into a wider debate that is likely to shape policy in the near 
future.  
 
A BRIEF INTRODUCTION TO RESPONSIBLE 
INNOVATION 
RI emerged with the growing demand for public engagement 
in decision making processes regarding new technologies 
(Owen, Macnaghten, Stilgoe; 2012, p. 751).  René von 
Schomberg's definition of the concept is widely referred to in 
RI literature, describing RI as: 
"A transparent, interactive process by which societal actors 
and innovators become mutually  responsive to each other 
with a view to the (ethical) acceptability, sustainability and 
societal  desirability of the innovation process and its 
marketable products (in order to allow a proper  
embedding of scientific and technological advances in our 
society).” (Von Schomberg 2011;  p.9).  
This definition reveals several important aspects of the 
concept: RI integrates a product  and a process dimension of 
a technology, seeking to achieve acceptable and even 
desirable outcomes (Stahl, 2012, p.709).  The product 
dimension incorporates the idea that science and innovation 
are steered to achieve desirable outcomes for society, seeking 
an inclusive, democratic way to answer the question ‘what 
sort of future do we collectively want innovation to create for 
Europe?’ (Owen et al, 2012). For this, RI aims for innovation 
being targeted towards “right impacts”, which, anchored in 
societal values, are supposed to solve societal challenges 
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(Von Schomberg, 2013). The process dimension focuses on 
the procedural values of innovation that involve inclusive 
engagement with society. Owen et al. (2013) have developed 
a framework that integrates four dimensions:   
• anticipation - understanding the complex interaction of a 
technology with its social and environmental surroundings;  
• reflexivity - requiring scientists and policy makers to reflect 
on their responsibilities and the underlying values of their 
work 
• inclusion - enabling early stakeholder and public 
engagement  
• responsiveness - the capacity to change shape and direction 
in reaction to stakeholder and public values, new 
information about potential impacts, alternatives.  
These dimensions are hardly new individually, however it is 
the emphasis on their integration and institutionalization that 
make the approach a novelty (Stilgoe, Owen & Macnaghten, 
2013).  
CASE STUDY - MON810 IN NORWAY 
Case Selection and Method 
Norway has been selected for the case study, as it is a pioneer 
in the holistic assessment of GMOs, evaluating both their 
physical and social impact since 1993 (Roger, 2015). The RI 
approach is present in the Norwegian Gene Technology Act , 2
which uniquely requires a demonstration of social benefit and 
contribution to sustainable development being in line with 
ethical considerations , for GMOs to be approved for release. 
MON810 is a Bt- maize that can be used to control maize 
insect pests including the larvae of the European corn borer, a 
moth that can seriously damage the corn harvest (Tefera et 
al., 2016). The assessment of MON810 is analyzed as it 
remains the only GMO that is authorized for cultivation in 
Europe. Safeguard measures by European Member States 
caused controversy and concerns about the politicization of 
risk assessment. It is thus interesting to evaluate in how far 
the Norwegian model could be seen as an example for EU 
Member States. 
The analysis is based on assessment reports by the Norwegian 
Environment Agency (NEA; Miljødirektoratet); GenØk – 
Centre of Biosafety, Scientific Committee on Food Safety 
(VKM), the Norwegian Biotechnology Advisory Board 
(NBAB) and the Norwegian Directorate for Nature 
Management (DN) as well on a range of secondary literature 
on the Norwegian assessment of GMOs. 
Regulatory Context  
As Norway is part of the European Economic Area (EEA), 
EU directives and regulations for the most part also apply to 
Norwegian assessments of applications for import, trade and 
cultivation of GMOs (Roger, 2015). In the event that a GMO 
application has been approved in the EU, Norwegian 
regulators can decide against it, if it presents potential health 
and environmental risk or if it violates the Norwegian Gene 
Technology Act (Rosendal, 2009). Like the European 
regulatory framework, the Act establishes that GMOs must 
prove to have no detrimental effects on the environment or 
human health, but further by stating that the deliberate release 
of genetically modified organisms should represent a “benefit 
to the community”, enable “sustainable development” and is 
ethically justifiable . 3
In the case of MON810, the Norwegian Ministry of 
Environment (KLD) has commissioned the NEA to deliver a 
final assessment of the case of MON810 with an overall 
recommendation. After scientific risk assessment by the 
Norwegian Food Safety Authority (MT), based on the basis 
of the Scientific Committee on Food Safety (VKM) – which 
concluded that cultivation of maize MON810 is unlikely to 
have any adverse effect on the environment in Norway 
(VKM, 2013) - and a societal assessment conducted by the 
NBAB – which concluded that MON810 is unlikely to 
contribute to sustainably development and societal utility - 
the NEA suggested not to authorize cultivation of MON810 
in Norway.  
RESPONSIBLE INNOVATION IN ACTION? 
The ARIR-Framework in assessing MON810 
In the assessment of MON810, sustainability effects, socio-
economic considerations and ethical concerns outweighed 
scientific risk assessments that suggested that the maize does 
not harm on environment and health (NBAB 2013). The 
Norwegian regulatory framework thus integrates product 
values of Von Schomberg’s definition of RI, which 
emphasizes “ethical acceptability, sustainability and societal 
desirability” (von Schomberg, 2011). In order to examine the 
procedural dimension of the Norwegian regulatory 
framework, the assessment of the Bt- maize MON810 will be 
evaluated in the light of the ARIR- Framework. 
Anticipation 
The assessment of MON810 has revealed anticipation by 
going beyond the evaluation of short-term impacts and 
further involved studies of potential far-off future scenarios, 
addressing the potential long-term threat that might be posed 
if the target insect develops resistance to the released protein. 
In order to discover wether the Bt-maize will increase 
productivity, the NBAB compares it to its closest non 
modified relative (Miljødirektoratet, 2015). Moreover, after 
having evaluated the crop's necessity, the NBAB points out 
that since the insect MON810 is targeted against is barely 
found in Norway, the possible societal problems that can be 
solved by cultivating the maize are therefore not relevant 
(NBAB, 2013). Furthermore, the NBAB  remarks that 
MON810 will lead to additional costs for society, farmers and 
other members of the production chain, as it would require a 
new set up of rules for coexistence and systems to keep 
MON810 separate from non-genetically modified maize 
(Miljødirektoratet, 2015). Taking this wide range of aspects 
into consideration, the NBAB concludes that – despite the 
positive outcome of scientific risk assessment - the 
cultivation of MON810 is a negative contribution to both 
community benefit and sustainability (NBAB, 2013).  
A problem that became apparent in the analysis, is the lack of 
data and independent research in both safety and societal 
assessments (Myhr & Rosendal, 2009). To what extend the 
Gene Technology Act places the responsibility on Norwegian 
authorities for finding and collecting data on sustainable 
development and societal utility, thus remains an unresolved 
legal question. 
Reflexivity  
As demonstrated in the level of anticipation, the Norwegian 
regulatory framework shows reflexivity by moving beyond 
the predominant reductionist frame within crop science 
laboratory practice, which does not take into account the 
technology’s integration in a broader socio-ecological system 
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(Myhr & Rosendal, 2009). Reflexivity has also been revealed 
in reports of different agencies. The NEA acknowledges the 
complexity and unpredictability of the relation of MON810 
and its social and ecological environment and points to a lack 
of societal information that prove its contribution to societal 
utility (Miljødirektorate, 2014).  
Nevertheless, the analysis of the assessment of MON810 has 
illuminated some issues that can be attributed to a lack of 
reflexivity. While the NBAB’s ecological sustainability 
assessment has revealed risks concerning resistance building 
of the target insect (NBAB, 2013), VKM’s environmental risk 
assessment has acknowledged uncertainties in this regard, but 
concludes that the cultivation of maize MON810 is unlikely 
to have any adverse effect on the environment in Norway 
(VKM, 2013). This indicates different interpretation of 
uncertainties, while for NBAB the uncertainty is defined as a 
risk, VKM interprets the absence of certainty as safety  The 4
interpretations illustrate the importance to reflect on the 
framing of the issue and underlying values that might be 
involved in the risk and societal assessments.  
Furthermore, since scientific risk assessment of MON810, 
conducted by the VKM GMO Panel, is based on information 
provided by Monsanto, EFSA and other member states as 
well as on peer-reviewed scientific literature (VKM, 2013, p.
3), there is a lack of independent, transparent research. 
Inclusion 
Norway has various procedures to engage the public and a 
diversity of stakeholders in decision making. First, the 
Norwegian regulatory framework provides public access to 
information on applications for GM crops approval 
(Binimelis & Myhr, 2015, p.18). Second, as done in the case 
of MON810 after the first application in 1999 and during the 
renewal in 2008, the NBAB conducts national hearings for 
each GMO notification (Miljødirektorate, 2014). Third, the 
NBAB tries to provide for inclusion by interweaving expert 
and stakeholder inputs and forms of values and knowledge 
(Binimelis & Myhr, 2015). The composition of NBAB 
reflects that expertise is not exclusively possessed by 
scientists but also by other relevant stakeholders that 
contribute a diversity of knowledge and experience. 
Responsiveness  
Norway’s regulatory system provides institutional structures 
and norms that have opened up the debate on the governance 
of GMOs and transcended it beyond their risk dimensions. It 
integrates societal advisory bodies parallel to the scientific 
advisory bodies and uses stakeholder and other public 
deliberative forums to consider the broader cultural, societal 
and ethical dimensions of the technologies (Macnaghten, 
2015, p.237). This has been explicitly shown in the case of 
MON810, where societal utility and social values were taken 
into account through public consultations, research programs 
and stakeholder engagement (NBAB, 2013). Nevertheless, 
high level of anticipation and inclusion alone does not 
improve decision making, if it is not responsive to these 
processes (Stilgoe et al. 2013). Rosendal (2008) argues that it 
is not entirely clear in how far these concerns are actually 
taken into account in the final decision. The lack of 
reflexivity - in terms of scientists’ and policy makers’ values 
responsibilities - might become a problem in this regard. 
It can be argued that the main reason for rejecting of 
MON810 in Norway is the lack of economic benefit rather 
than cultural and ethical concerns (Rosendal, 2008). Due to 
geographical conditions in Norway, proposed GMOs had 
little practical utility for Norwegian farmers. Thus, the GMO 
issue has not been very controversial in Norway (Rosendal, 
2008). As the Norwegian public is generally against 
biotechnology and farmers advertise with “GMO-free zones”, 
a GMO that might contribute to sustainable development and 
is economically beneficial for farmers might raise debate and 
controversy (Rosendal, 2008; Myhr & Rosendal, 2009). 
Learning from the European issues regarding GMO 
regulation, responsive governance options are a significant 
factor to prevent such controversy. The RI framework offers 
tools to better integrate the four dimensions in order to make 
GMO governance more responsive.  
Towards Responsible GMO Governance  
First, a tool offered by the RI framework that could enhance 
anticipation is an independent, publicly funded 
interdisciplinary research programme (Macnaghten, 2015) 
with social sciences and life sciences as equal partners. Such 
a program would help to investigate on how the Norwegian 
societal and scientific assessment could be better integrated 
to constructively arrive at a common ground. Furthermore, 
before thinking about how they could be otherwise 
configured, there is need to contextualize GM crop's social 
and ethical impacts. This involves discussions about the 
initial purposes of the technology in regard to the neoliberal 
political environment in which they were promoted. Second, 
reflexivity in the Norwegian regulation can be improved by 
initiatives that encourage scientists and policy makers to 
reflect on their own responsibilities and to be aware of the 
limits of their current knowledge and the framing of the issue 
(Stilgoe et al, 2013). As evident in the case of MON810, it is 
important that scientists and policy makers are mindful of the 
underlying values that frame their research. As has been done 
in NBAB, an advancement in scientific assessment may be 
the development of multidisciplinary collaboration and 
trainings that brings together social scientists and ethicists in 
scientific laboratories (Macnaghten, 2015). Third, the 
independent research program should aim to enhance 
inclusion by engaging a multiple range of stakeholders in the 
scientific assessment as well as societal assessment of 
GMOs. To enhance deliberation between different Norwegian 
interest groups, the program should help to identify common 
definitions, ensure wide and diverse participation and create 
support structures that allow people to form mature and 
informed perspectives and a sense of commitment for 
o n g o i n g e n g a g e m e n t . T h e e n h a n c e m e n t a n d 
institutionalization of the anticipatory, inclusive and reflexive 
dimension will then lead to improved institutional capacities 
that can better respond to societal concerns and changing 
circumstances.  
CONCLUSION 
To conclude, this paper has investigated how the responsible 
innovation framework can provide tools for more responsive 
GMO governance in order to move the European debate on 
biotechnology out of its current sterile deadlock. By 
transcending the dimension of risk and addressing the 
complexity of the technology’s socio-ecological context, RI 
seeks to steer innovation towards the “right impacts” in order 
to contribute to a desirable future. This involves deeply 
interrelated product and process dimensions. The case study 
revealed that arriving at more responsive governance options 
requires institutionalization and integration of both 
dimensions. While the Norwegian GTA establishes the 
product values sustainable development and societal utility, 
the regulatory framework has demonstrated shortcomings in 
the integration of the procedural values. Indeed, the 
Norwegian model has institutional capacities to ensure broad 
anticipation that transcends the dimension of risk and enables 
considerably wide stakeholder and public engagement. 
However, the framework lacks reflexivity, which includes the 
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capacity of researchers to be mindful about their 
responsibilities, values and limitations, which can result in a 
lack of responsiveness. Since the Norwegian public is 
generally against GMOs, vindication of an application - 
although gone through societal impact assessment - may raise 
controversy in the future. If the four dimensions anticipation, 
reflexivity, inclusion and responsiveness are integrated and 
institutionalized more deeply and coherently, the infertile 
GMO controversy that has been experienced in Europe, could 
possibly be prevented in Norway.  
Having learned from RI, the Norwegian model could then 
function as an example for European Member States. 
Implementing regulations like the Norwegian GTA paired 
with RI tools that promote anticipation, reflexivity, inclusion 
and responsiveness in less responsive European regulatory 
contexts, might open up the sterile debate about benefits and 
risks of biotechnology and offer new possibilities for using 
GMOs responsibly. However, this requires constant and 
critical reflection on the underlying purposes of technology 
and the question how it can contribute towards a better 
future . Nevertheless, given complexity and uncertainty of its 
impacts, a critical reflection on the technology's purposes 
needs to be paired with consideration of less risky and more 
beneficial alternatives (Hartley et al, 2016). If the goal of the 
technology is to feed the world and to address the problem of 
malnutrition (Borlaug, 2000), alternatives to producing 
sufficient food for the entire world population need to be 
investigated. Therefore, it is time to open up the narrow 
debate on risks and benefits of biotechnology to a wide 
ranging discussion about sustainable food and agricultural 
systems.  
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